Rheumatology

Secure your place at CoreSkills.

Head to rheumatology.org.uk slash CoreSkills or Google BSR CoreSkills

You're listening to the Talking Rheumatology podcast brought to you by the British Society for Rheumatology.

So good afternoon.

I'm really pleased to be joined by some of the team at University of Hospital Leicester NHS Trust.

We'll end it there.

Thank you very much.

Thank you for listening to Talking Rheumatology, brought to you by BSR.

statistics on when you go on a biologic, a new therapy, a JAK inhibitor, whatever, people don't usually respond and stay on the drugs long enough.

Is that because we have so many to choose from and we have a low threshold to change? This study from the British Society of Rheumatology, they have a psoriatic arthritis registry of 815 patients.

And the good news was at 12 months with their index drug, new drugs, you know, Biologic target synthetics, 24% had minimal disease activity.

Great.

Again, this is putting all this data together from 52 studies.

While tea may increase your gout risk, gout coffee will decrease your gout risk and decrease it by 46%.

The journal Advances in Rheumatology had a report this week from Panlar looking at the TB and latent tuberculosis burden in Latin America.

They reviewed the Panlar registry that had 590 IMID patients Taking a wealth of the drugs that you and I use, half are on glucocorticoids, 44% are on biologic DMARDs, mostly TNF inhibitors, 29%, JAK inhibitors, 27% were on conventional DMARDs.

Rumor has it, it's time to talk rheumatology, real conversations and clinical truth by nurses for nurses.

This is Rumor Has It from the Rheumatology Nurses Society.

Let's get into it.

Hello and welcome to Rumor Has It.

I couldn't resist.

Rheumatology had become fascinating to me when I was doing consulting for pharma because I was asked to do a lot of comparative effectiveness work with the claims data.

And comparing biologics is messy, complicated, and required a lot of methodological rigor.

And I absolutely loved it.

Your commitment to rigor and precision strengthens the insights we can draw from data and ultimately improves the care for everyone living with autoimmune and rheumatic diseases.

Thank you all for listening to this podcast.

ACR Journals on Air is a production of the American College of Rheumatology.

Please follow at AC Room on social media, email us at podcast at rheumatology.org and rate and subscribe to our podcast at acrjournalsonair.org or wherever you get your podcasts.

That was just a bit of what you'll hear from our guest today as we discuss the science and ideas that matter to people living with chronic pain and those who love and care for them.

Dr. Susan Murphy is a professor and researcher at the University of Michigan in the Department of Physical Medicine and Rehabilitation and in the Rheumatology division.

She originally trained and practiced as an occupational therapist before turning to research.

Dr. Murphy specializes in studying strategies for managing fatigue and pain in people with chronic conditions.

Essentially any part of the body can be affected.

Rheumatology is the specialty of medicine, the subspecialty that's a small one, but a very interesting one because we are responsible for diagnosing and also managing the long-term treatment for patients with these rheumatic diseases.

What are some of the most common diseases or conditions that listeners may have heard of before?

So you could definitely group them in this arthritis family, but it's important to distinguish them.

Maybe I'll pause here and see what your preliminary thoughts are.

Rheumatology hasn't been consulted yet, so things are still pretty general at the moment.

This is classic open and shut case of whatever Janet's about to say.

Janet, you have quite a good handle on general medicine as well as rheumatology.

And she was referred to rheumatology for fever of unknown origin.

Here we go.

Rheumatology showing up.

Okay, so this is a very unusual case at this point, but I do kind of appreciate that internal medicine, ID, respirology, and hematology all took the right tack, which is do not assume right out of the gate that this is the weirdest thing you've ever heard of, or like Blau syndrome or whatever hereditary sarcoid.